Stock Markets News
ELF Beauty earnings analysis: questions answered and next catalysts
ELF Beauty earnings analysis: questions answered and next catalysts
ELF Beauty Inc (ELF) trades at $111.68 (-1.72%) as of Nov 5, 1:15 PM EST. After-hours it had jumped to $119.15. The intraday high was $123.13, a 52-week high, so the early gains have reversed. The quarter was strong, but the stock is still being priced on how durable the growth is.
ELF Beauty Inc (ELF): FY2027 Q2 EPS $1.21 vs $0.57 est || Revenue $520.8M vs $469.27M est (+51% YoY) || Gross margin ~71% (+160 bps) (earnings data as of Nov 4, 2026)
Questions Answered
- Is rhode durable? It is the main debate. Management’s evidence is that the brand is expanding to 19 European countries through Sephora, which launched Sep 30. The CFO said 75% of rhode’s following is outside the US. A $17.7M fair value adjustment on the acquisition also points to revenue running ahead of plan. (Nov 4, 2026)
- Was Q1’s margin a one-off? Q1’s 83% gross margin included about $50M of non-recurring tariff refunds. (Aug 6, 2026) Q2’s 71% is a cleaner read. It was helped by lower year-over-year tariffs and mix, and partly offset by price investments.
- Can guidance keep rising? Yes. FY2027 net sales growth guidance rose to 22–24%, with revenue of $2.00–2.03B (prior $1.94–1.97B). Adjusted EPS guidance rose to $3.82–3.86, above the $3.63 consensus. Analysts at JPMorgan, Citi, Jefferies and others raised price targets.
Questions Still Open
- Core brand health: In Q1, the legacy e.l.f. brand’s organic sales fell by a high-single-digit percentage once rhode’s ~$160M contribution is stripped out. (Aug 6, 2026) The Q2 articles found don’t break out the core brand’s organic trend, so this is not confirmed as resolved.
- Tougher comparisons: rhode is lapping its first year at Sephora US. Consensus for the Dec quarter implies $537M of revenue but only $0.86 of EPS.
- Quality of the beat: The EPS surprise of +112% is large, but tariff refunds and acquisition accounting adjustments flatter the headline numbers.
Next Catalysts
- Next earnings (FY2027 Q3): tentatively Feb 3, 2027. Consensus is EPS $0.86 and revenue $537.29M. In February 2026 the stock fell 9.37% despite a beat, so expectations matter.
- rhode Europe sell-through: early data from the 19-country Sephora launch.
- Hair care launch: analysts cite e.l.f. Hair, in a $17B category, as incremental growth.
- Estimate revisions: FY2027 EPS consensus is $3.67, below the new guidance midpoint of $3.84. Consensus has risen 2.6% over 90 days, so further upgrades are possible.
- Tariff policy: refunds and lower duties boosted margins. A reversal would hit them.
Bull vs Bear
- Bull: 31 straight quarters of sales growth, guidance above consensus, and a stock up 29.4% over 3 months and 45.6% YTD (as of Nov 5, 2026).
- Bear: After an 88% six-month run, much of the good news may already be priced in. Growth depends heavily on one acquired brand. The mean price target before earnings was about $117, only ~5% above the price then.